CDK9-IN-2 T14918
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CDK9-IN-2 is a special CDK9 inhibitor extracted from patent WO/2012131594A1 (compound CDKI(8)) and has an IC50 of 5 nM and 7 nM in A2058 skin cell line (72 hours) and H929 multiple myeloma cell line (72 hours), respectively.
CAS nr:
1263369-28-3
Purity:
98%
Molecular Weight:
425,93
SMILES:
N[C@H]1CC[C@@H](CC1)Nc1cc(c(Cl)cn1)-c1cccc(NCc2cccc(F)c2)n1
Formula:
C23H25ClFN5
Pathway:
Cell Cycle/Checkpoint,Others
Target:
CDK,Others
